News About: Pharm. Industry
Inseong Info to associate with KTF for mobile diabetic controls.
Inseong Information Inc., an IT specialized company, announced that the company had associated with KTF for a commercialized mobile diabetic control service called "Hicare Doctor's Diabetic Control" starting from Feb....
Medipost/Samsung Hospital joint to develop a new composite for lung disease.
Medipost, a biotech company, has developed a therapeutic composite material for the treatment of lung diseases by the use of adult stem cells in association with the Dept. of Pediatrics, Seoul Samsung Hospital.
The...
Keunwha declared 10 billion won of Somalgen sales in 2006.
Keunwha took a declaring ceremony for the sales of Somalgen to achieve 10 billion won in 2006 during the 20th anniversary of Somgalen market launching.
In the meeting the company invited Prof. Lee Soo-ho, Seoul Asa...
Number of drug adverse reaction reports on the rise.
Given the recent atmosphere of which the drug safety problems seriously alerted to the public concerns, the drug adverse reaction report doubled in its number, showing a sharp rising trend from 363 cases in 2001 to 14...
Samjin in strategic alliance with ImQuest over anti-viral drug development.
Samjin announced to make a strategic alliance with ImQuest, an American company, for the clinical research of new anti-viral drugs developed by Samjin according to Fox 5 news, a foreign correspondence.
The news sai...
Dong-A distributing a new type of Quinolone antibiotics.
Dong-A made an agreement with Toyama Chemical of Japan on Jan. 20 for the exclusive distribution of Garenoxacin, a new type of quinolone antibiotics, in Korea.
Garenoxacin is a new and unique compound, developed by...
Jinyang to patent an anti-cancer therapy in America.
Jinyang pharmaceutical company, a Kosdaq listed company of Korea, announced that the company took a patent registration of an anti-leukemia drug in the United States under the number of Pat. No. 6989143.
The comp...
Korean drug companies exploring overseas markets for survival.
The pharmaceutical industry understood that the domestic markets already reached its limits for their further growth and therefore looked for the overseas markets.
After the medical reform programs are soft landed ...
Alcon CEO visiting Korea for investment.CEO Kerry Raymond of Alcon pharmaceutical Inc. located at Texas, a multinational drug corporation, visited to Korea on Jan. 24 for 3 days.
Since the company foundation in 194...
|
Otzuka Korea successfully finished new year and POA meetings.
Otzuka Korea took a new year inauguration ceremony and general meeting at Seoul Educational Culture Center in attendance of about 160 middle and high executive staffs on Jan. 16 under the title of "The performance ce...
